An interventional study of Solution-Focused Approach Education in Breastfeeding Avoidance and Breastfeeding Self-efficacy, sponsored by Karadeniz Technical University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-27.
Sponsored by Karadeniz Technical University · Not applicable, Interventional, and Health services research
Breastfeeding provides important short- and long-term benefits for maternal and infant health. However, many women, particularly primiparous mothers, experience psychological, social, and physiological difficulties during lactation and may show breastfeeding avoidance behavior. Breastfeeding self-efficacy, defined as a mother's belief in her ability to initiate and maintain breastfeeding, is a key determinant of breastfeeding success. This randomized controlled trial is currently evaluating the effect of a solution-focused approach (SFA) training program on breastfeeding avoidance and breastfeeding self-efficacy in primiparous mothers. Eligible participants are randomly assigned (1:1) to an intervention group, which receives four weekly, 45-minute online group sessions based on solution-focused techniques (e.g., scaling questions, reframing, EARS, miracle question, and exception-seeking questions), or a control group, which receives routine standard postpartum care. Breastfeeding avoidance and breastfeeding self-efficacy are measured before and after the intervention using validated scales. The study aims to determine whether SFA-based training reduces breastfeeding avoidance and increases breastfeeding self-efficacy in primiparous mothers.
1,081 studies on the registry are indexed under Breast Feeding; 217 are open to participants now.
This study's planned enrollment of 80 is below the median of 100 across 844 interventional studies indexed under Breast Feeding.
Browse Breast Feeding studies →Karadeniz Technical University is the lead sponsor of 153 studies on the registry; 22 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Being 18 years of age or older.
Having given birth for the first time (primiparous).
Having delivered a single, live, healthy infant.
At least 6 weeks having elapsed since childbirth (completion of the postpartum period).
Currently breastfeeding or intending to continue breastfeeding.
Being able to read, write, and communicate in Turkish.
Voluntarily agreeing to participate in the study and providing written .
Having access to a smartphone, computer, or the internet.
Exclusion Criteria:
Being multiparous.
Prolonged mother-infant separation due to the infant's need for neonatal intensive care.
Having a diagnosis of a serious psychiatric disorder.
Reporting an inability to participate regularly in the study procedures.
Incomplete completion of the data collection forms.
Voluntarily withdrawing from the study at any stage.
Not having access to a smartphone, computer, or the internet.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive four weekly, 45-minute online group sessions based on the solution-focused approach, delivered by a trained researcher via video conference. Techniques include exploration, scaling, exception-seeking and miracle questions, reframing, compliments, and EARS. Each session includes a homework assignment. Participants also receive routine standard postpartum care.
Behavioral: Solution-Focused Approach Education
Participants receive routine standard postpartum care only and no solution-focused training during the study period.
A solution-focused approach education program will be provided to primiparous mothers in the intervention group in addition to routine postpartum care. The intervention aims to reduce breastfeeding avoidance and improve breastfeeding self-efficacy.
Breastfeeding Avoidance Level
Breastfeeding avoidance level will be assessed using the Breastfeeding Avoidance Scale before and after the intervention. Changes in scores will be compared between the intervention and control groups.
Time frame: At baseline before the intervention and immediately after completion of the intervention.
Breastfeeding Self-Efficacy
Breastfeeding self-efficacy will be assessed using a validated breastfeeding self-efficacy scale before and after the intervention. Changes in scores will be compared between the intervention and control groups.
Time frame: At baseline before the intervention and immediately after completion of the intervention.
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for Dec 2026, 3 months after the start.
Of 502 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 3 months is below that.
Counting every sponsor, half of 510 studies reached it within 12 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Karadeniz Technical University →